Taran Therapeutics, Inc.
PrivateLast Round
Corporate Funding
Feb 20, 2024
Total Funding Raised
$2M
Company Overview
Taran Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Burlingame, California. Its latest recorded funding round was a Corporate Funding round in February 2024.
Taran Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing monoclonal antibody therapies for hematology, oncology, and inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taran Therapeutics, Inc. Comparables
Compare Taran Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roivant Sciences | 80% | |
| Solu Therapeutics | 80% | |
| I-Mab Biopharma | 71% |
For institutional investors. Book with your work email.
Taran Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Taran Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Taran Therapeutics, Inc.'s valuation, stock price, and market status.
Is Taran Therapeutics, Inc. a public or private company?
Taran Therapeutics, Inc. is a private company.
What is the current stock price of Taran Therapeutics, Inc.?
Taran Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Taran Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Taran Therapeutics, Inc. worth (valuation)?
Valuation information for Taran Therapeutics, Inc. is not publicly available.
Can I buy Taran Therapeutics, Inc. stock?
Taran Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Taran Therapeutics, Inc.'s last funding round?
Taran Therapeutics, Inc.'s most recent funding round was Corporate Funding on February 20, 2024.
Who are the main investors in Taran Therapeutics, Inc.?
Investor information for Taran Therapeutics, Inc. is not publicly disclosed.
Will Taran Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Taran Therapeutics, Inc..
How can I track Taran Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Taran Therapeutics, Inc.'s shares on secondary markets.